NASDAQ · Drug Manufacturers - Specialty & Generic

IM Cannabis Corp. (IMCC) Stock

$1.58 -8.14% NASDAQ: IMCC Healthcare

Valuation

MetricValue
Price$1.58
Market Cap$954195
P/E Ratio-1.13
P/B Ratio2.28
P/S Ratio0.32
EPS (TTM)$-2.67
52-Week High$77.10
52-Week Low$1.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-107.40%
ROA-27.01%
ROCE-239.67%
Gross Margin-20.00%
Operating Margin-21.82%
Net Margin-19.59%
Debt/Equity3.44
Current Ratio0.68

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$54.0M$49.0M$54.0M$55.0M
Operating Profit$-23.0M$-31.0M$-13.0M$-10.0M$-12.0M
Net Profit$-18.0M$-189.0M$-9.0M$-11.0M$-11.0M
EPS$-1188.00$-4856.40$-133.50$-135.30$-80.10
Op Margin-67.6%-56.7%-26.2%-18.9%-21.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$287.0M$61.0M$49.0M$39.0M$32.0M
Total Liabilities$82.0M$37.0M$35.0M$36.0M$35.0M
Cash$14.0M$2.0M$2.0M$1.0M$3.0M
Borrowings$29.0M$12.0M$14.0M$18.0M$16.0M

Latest News

IM Cannabis Closes Convertible Note Financing MT Newswires · Jul 1, 2026 IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing PR Newswire · Jul 1, 2026 IM Cannabis to Sell European-Focused Assets MT Newswires · Jun 18, 2026 IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million PR Newswire · Jun 18, 2026 Top Premarket Gainers MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-13.0M$-8.0M$-1.0M$5.0M
Investing Cash Flow$-14.0M$-3.0M$-2.0M$-1.0M$-1.0M
Financing Cash Flow$13.0M$-2.0M$8.0M$4.0M$-5.0M
Net Cash Flow$5.0M$-11.0M$-1.0M$-1.0M$2.0M
Free Cash Flow$-39.0M$-14.0M$-9.0M$-1.0M$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-5.59
FCF Yield-7.18%
Quick Ratio0.58
Interest Coverage-2.29
Return 1Y-95.24%
Return 3Y-97.35%
Return 5Y-99.95%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKANAkanda Corp. $1.76 -1.12% -0.01 $56964 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
GRIGRI Bio, Inc. $1.74 +3.57% -0.04 $3.80M 0.00%
JAGXJaguar Health, Inc. $4.79 +5.74% 0.00 $2.08M 0.00%
MOVECorvex, Inc. $9.84 +0.31% -0.93 $7.47M 0.00%

About IM Cannabis Corp.

IM Cannabis Corp. (IMCC) stock trades at $1.58 with a market capitalization of $954195. The stock is valued at a price-to-earnings (P/E) ratio of -1.13, price-to-book of 2.28, price-to-sales of 0.32. Over the past 52 weeks the stock has ranged between $1.55 and $77.10, and currently trades 98.0% below its 52-week high.

On profitability, IM Cannabis Corp. generates a return on equity (ROE) of -107.40%, return on capital employed of -239.67%, an operating margin of -21.82%, a net profit margin of -19.59%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides